课题基金 / 基金详情

Cellular Response to Misfolded Rhodopsins.

Cellular Response to Misfolded Rhodopsins.
细胞对错误折叠视紫红质的反应。
批准号:
8757005
负责人:
HYUNG D RYOO
金额:
$42.38万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2018-07-31

项目摘要

项目成果

HYUNG D RYOO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of this project is to understand how cells cope with mutant Rhodopsin-1 (Rh-1) proteins that underlie age-related retinal degeneration in the Drosophila model for Autosomal Dominant Retinitis Pigmentosa (ADRP). The Rh-1 alleles in this model impair the encoded protein's folding property and impose stress to the endoplasmic reticulum (ER). Healthy young cells exhibit robust ER stress-response mechanisms that allow the afflicted photoreceptors to survive until old age. On the other hand, old cells succumb to stress by activating cell death pathways, leading to age-related retinal degeneration. A better understanding of these pathways may allow the development of effective therapeutic strategies against this disease. Through our unique Drosophila-based approach, we identified a number of cellular response mechanisms to mutant Rh-1 that were unexpected, yet likely to play important roles in ADRP. Here, we propose three Specific Aims to investigate those mechanisms. In Aim 1, we plan to examine how cells degrade misfolded rhodopsins to reduce stress in the ER. We had previously established that a central ubiquitin ligase involved in this process, HRD1, can significantly delay the course of retinal degeneration in the Drosophila ADRP model. HRD1 requires the cooperation of other proteins that help recognize and degrade misfolded Rh-1. Through a genetic screen, we identified a poorly characterized carboxypeptidase as one of the most potent factors that help reduce misfolded Rh-1 levels. Here, we propose to validate the intriguing idea that HRD1-mediated degradation of misfolded rhodopsin requires this carboxypeptidase of unknown function. In Aim 2, we propose to determine the role of translational inhibitors in the ER stress response. Translational inhibition s a common outcome of cellular stress, and specifically in response to misfolded protein overload in the ER, cells activate the translational inhibitor PERK to reduce the burden on the ER protein folding system. Unexpectedly, we discovered that another translational inhibitor, 4E-BP, is induced downstream of PERK. As 4E-BP is known for its effects in enhancing stress resistance and prolonging lifespan, we plan to test the functional significance of 4E-BP induction in the ADRP model. Moreover, we propose to determine how 4E-BP protects cells against ER stress. In Aim 3, we propose to study how ER stress induces cell death. Many cell death regulators localize to the mitochondrial outer membrane for their function, and we hypothesize that a specific cell death pathway conveys stress signals from the ER to the mitochondria. Through a genetic screen, we identified two Cyclin Dependent Kinases (CDKs) that are unexpectedly involved in this cell death signaling. Here, we propose to test the idea these CDKs form a linear pathway that promotes pro-apoptotic events at the mitochondrial outer membrane. The genes of interest here will be further examined for their roles in age-related retinal degeneration in a Drosophila model of ADRP. A successful outcome of this proposal is expected to bring conceptual advances to the three poorly understood areas of ER stress response that are directly related to the pathology of ADRP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational control of stress response signaling
Translation control of stress response and innate immunity
Quality control mechanisms against misfolded rhodopsins in Drosophila.
Unfolded Protein Response in Eye Development and Disease
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: